Recruiting

mHealth Application

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT06252545

Conditions

Pancreas Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

semistructured interviews

feedback

Study Details

Brief summary:

To develop a culturally tailored informational mobile application and test whether it will increase participation among Black pancreatic cancer subjects in clinical trial discussions with their care team.

This project aims to identify and address barriers to enrollment of Black subjects in pancreatic cancer clinical trials using a culturally informed mobile health application to promote participation.

The clinical trial education and communication needs of Black people with pancreatic cancer will be determined. A new mHealth application for clinical trial education and communication tailored to subject needs will be developed. It was hypothesized that a culturally tailored informational mobile application will increase the participation of Black subjects in clinical trial discussions with their care team among the target population.

This study focuses on Black pancreatic cancer subjects, who experience higher mortality rates and lower clinical trial participation than White subjects. Research shows that the disparity between clinical trial participation is in part due to inequitable recruitment practices. This study will use mobile application technology (mHealth app) as an educational, communication, audit, and feedback tool to promote patient-initiated clinical trial discussions among Black people with pancreatic cancer and their cancer care team.

Conditions

Pancreas Cancer

Study ID

NCT06252545

Start date

Feb 2, 2024

Status verified date

May, 2026

Completion date

Feb 1, 2027

Anticipated

Primary completion date

Feb 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria

Participants must meet the following inclusion criteria in order to participate in communication \& education interview component of the study:

1. Informed consent obtained to participate in the study
2. 18 years or older
3. English speaking
4. Able and willing to participate in a 1-hour interview
5. History of pancreatic cancer diagnosis
6. Identify as Black

Exclusion Criteria:

All participants meeting any of the following exclusion criteria will be excluded from the study:

1. Inability to read and speak English
2. Dementia altered mental status, or any psychiatric condition that would prohibit understanding or rendering of informed consent as determined by the study physician.

Study Design

Enrollment

26 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

other: Interview Group

Subjects with pancreatic carcinoma who joined the interview group.

other: User Testing Group

Subjects with pancreatic carcinoma who joined the user testing group

Interventions

semistructured interviews

Black subjects with pancreatic cancer will provide insight on their experience discussing clinical trials and preferences for communicating clinical trial information

feedback

Black subjects with pancreatic cancer will provide feedback on mHealth app prototype.

Primary outcome measure

  • The clinical trial education and communication needs [ Time Frame: Up to 1 month ]

Central Contacts and Locations

Locations

UNC Lineberger Comprehensive Cancer Center

Recruiting

Chapel Hill, North Carolina, United States, 27599

Contacts

Principal Investigator:

Jen Jen Yeh, MD

Medical College Of Wisconsin

Recruiting

Milwaukee, Wisconsin, United States, 53226

Contacts

Principal Investigator:

Ugwuji Maduekwe, MD, MMSc, MPH

More Information

Sponsor

UNC Lineberger Comprehensive Cancer Center

Last update posted

May 14, 2026

Last verified

May, 2026

Keywords

  • ethnicity
  • black
  • application

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center on 2026-05-14.